{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30911084", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "19"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "03", "Day": "25"}], "Language": ["eng"], "ELocationID": ["5078", "10.1038/s41598-019-41532-3"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "9", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Mar", "Day": "25"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre.", "Pagination": {"StartPage": "5078", "MedlinePgn": "5078"}, "Abstract": {"AbstractText": ["Complementary medicine (CM) is used by one third to one half of cancer patients throughout the world. The objective of this study was to describe the prevalence of CM use and the potential for interactions with cancer treatments in an academic oncology centre. A cross-sectional study was conducted among patients undergoing current cancer treatment. Among 132 included patients, 56% had used CM since their cancer diagnosis and 45% were using CM during cancer treatment at the time of the survey. The main CM used were green tea (35%), herbal tea (35%), homeopathy (27%), dietary supplements (27%), and herbal medicines (27%). A small majority of patients (58%) spontaneously mentioned the use of CM to their oncologist. Of 42 identified combinations of concomitant use of biologically based CM and anticancer agents among the study patients, the potential for pharmacokinetic interactions of clinical relevance was not expected in 17 combinations (40%), hypothetical and deemed unlikely in 23 (55%), and of probable low clinical relevance in 2 (5%). Considering the high prevalence of CM use, active enquiries should be made by healthcare professionals to detect symptoms that may relate to CM tolerance and effects or that suggest interactions between CM and cancer treatments."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy Service, Geneva University Hospitals, Geneva, Switzerland."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland."}], "LastName": "Jermini", "ForeName": "M\u00e9gane", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Primary Care and Public Health (Unisant\u00e9), University of Lausanne, Lausanne, Switzerland."}, {"Identifier": [], "Affiliation": "Institute of Family Medicine, University of Fribourg, Fribourg, Switzerland."}], "LastName": "Dubois", "ForeName": "Julie", "Initials": "J"}, {"Identifier": ["0000-0003-2007-2995"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Primary Care and Public Health (Unisant\u00e9), University of Lausanne, Lausanne, Switzerland. pierre-yves.rodondi@unifr.ch."}, {"Identifier": [], "Affiliation": "Institute of Family Medicine, University of Fribourg, Fribourg, Switzerland. pierre-yves.rodondi@unifr.ch."}], "LastName": "Rodondi", "ForeName": "Pierre-Yves", "Initials": "PY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland."}], "LastName": "Zaman", "ForeName": "Khalil", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Pharmacology, Department of Laboratories, Lausanne University Hospital, Lausanne, Switzerland."}], "LastName": "Buclin", "ForeName": "Thierry", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Pharmacology, Department of Laboratories, Lausanne University Hospital, Lausanne, Switzerland."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland."}], "LastName": "Csajka", "ForeName": "Chantal", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland."}], "LastName": "Orcurto", "ForeName": "Angela", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Pharmacology, Department of Laboratories, Lausanne University Hospital, Lausanne, Switzerland."}], "LastName": "E Rothuizen", "ForeName": "Laura", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Tea"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["methods"], "DescriptorName": "Complementary Therapies"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tea"}, {"QualifierName": [], "DescriptorName": "Young Adult"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Eisenberg DM, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. Jama. 1998;280:1569\u20131575. doi: 10.1001/jama.280.18.1569.", "ArticleIdList": ["10.1001/jama.280.18.1569", "9820257"]}, {"Citation": "Clarke, T. C., Black, L. I., Stussman, B. J., Barnes, P. M. & Nahin, R. L. Trends in the use of complementary health approaches among adults: United States, 2002\u20132012. Natl Health Stat Report, 1\u201316 (2015).", "ArticleIdList": ["PMC4573565", "25671660"]}, {"Citation": "Eardley S, et al. A systematic literature review of complementary and alternative medicine prevalence in EU. Forschende Komplementarmedizin (2006) 2012;19(Suppl 2):18\u201328. doi: 10.1159/000342708.", "ArticleIdList": ["10.1159/000342708", "23883941"]}, {"Citation": "Klein SD, Torchetti L, Frei-Erb M, Wolf U. Usage of Complementary Medicine in Switzerland: Results of the Swiss Health Survey 2012 and Development Since 2007. PloS one. 2015;10:e0141985. doi: 10.1371/journal.pone.0141985.", "ArticleIdList": ["10.1371/journal.pone.0141985", "PMC4626041", "26513370"]}, {"Citation": "Molassiotis A, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Annals of oncology: official journal of the European Society for Medical Oncology. 2005;16:655\u2013663. doi: 10.1093/annonc/mdi110.", "ArticleIdList": ["10.1093/annonc/mdi110", "15699021"]}, {"Citation": "Tascilar M, de Jong FA, Verweij J, Mathijssen RH. Complementary and alternative medicine during cancer treatment: beyond innocence. Oncologist. 2006;11:732\u2013741. doi: 10.1634/theoncologist.11-7-732.", "ArticleIdList": ["10.1634/theoncologist.11-7-732", "16880232"]}, {"Citation": "van der Weg, F. & Streuli, R. A. Use of alternative medicine by patients with cancer in a rural area of Switzerland. Swiss medical weekly133, 233\u2013240, doi:2003/15/smw-10160 (2003).", "ArticleIdList": ["12811673"]}, {"Citation": "Inglin, S., Amsler, S., Jeangros, C., Pargoux-Vallade, C. & Sappino, A.-P. Evaluation du recours aux m\u00e9decines compl\u00e9mentaires chez les patients en suivi oncologique. Revue m\u00e9dicale suisse: revue officielle de la Soci\u00e9t\u00e9 m\u00e9dicale de la Suisse romande et de la Soci\u00e9t\u00e9 suisse de m\u00e9decine interne (2008).", "ArticleIdList": ["18616209"]}, {"Citation": "Werneke U, et al. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer. 2004;90:408\u2013413. doi: 10.1038/sj.bjc.6601560.", "ArticleIdList": ["10.1038/sj.bjc.6601560", "PMC2410154", "14735185"]}, {"Citation": "Salamonsen A. Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine. Forschende Komplementarmedizin (2006) 2015;22:24\u201329. doi: 10.1159/000376555.", "ArticleIdList": ["10.1159/000376555", "25824401"]}, {"Citation": "Medicine, I. O. Complementary and Alternative Medicine in the United States. (The National Academies Press, 2005).", "ArticleIdList": ["22379647"]}, {"Citation": "Frenkel M, et al. Integrating dietary supplements into cancer care. Integrative cancer therapies. 2013;12:369\u2013384. doi: 10.1177/1534735412473642.", "ArticleIdList": ["10.1177/1534735412473642", "23439656"]}, {"Citation": "Timbo BB, Ross MP, McCarthy PV, Lin CT. Dietary supplements in a national survey: Prevalence of use and reports of adverse events. Journal of the American Dietetic Association. 2006;106:1966\u20131974. doi: 10.1016/j.jada.2006.09.002.", "ArticleIdList": ["10.1016/j.jada.2006.09.002", "17126626"]}, {"Citation": "Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer. 2011;11:196. doi: 10.1186/1471-2407-11-196.", "ArticleIdList": ["10.1186/1471-2407-11-196", "PMC3123324", "21609461"]}, {"Citation": "De Smet PA. Health risks of herbal remedies: an update. Clinical pharmacology and therapeutics. 2004;76:1\u201317. doi: 10.1016/j.clpt.2004.03.005.", "ArticleIdList": ["10.1016/j.clpt.2004.03.005", "15229459"]}, {"Citation": "Niggemann B, Gruber C. Side-effects of complementary and alternative medicine. Allergy. 2003;58:707\u2013716. doi: 10.1034/j.1398-9995.2003.00219.x.", "ArticleIdList": ["10.1034/j.1398-9995.2003.00219.x", "12859546"]}, {"Citation": "Olaku O, White JD. Herbal therapy use by cancer patients: a literature review on case reports. European journal of cancer. 2011;47:508\u2013514. doi: 10.1016/j.ejca.2010.11.018.", "ArticleIdList": ["10.1016/j.ejca.2010.11.018", "PMC3057114", "21185719"]}, {"Citation": "Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 2004;22:2489\u20132503. doi: 10.1200/JCO.2004.08.182.", "ArticleIdList": ["10.1200/JCO.2004.08.182", "15197212"]}, {"Citation": "McLay JS, Stewart D, George J, Rore C, Heys SD. Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? European journal of clinical pharmacology. 2012;68:811\u2013819. doi: 10.1007/s00228-011-1181-6.", "ArticleIdList": ["10.1007/s00228-011-1181-6", "22166933"]}, {"Citation": "Haefeli WE, Carls A. Drug interactions with phytotherapeutics in oncology. Expert opinion on drug metabolism & toxicology. 2014;10:359\u2013377. doi: 10.1517/17425255.2014.873786.", "ArticleIdList": ["10.1517/17425255.2014.873786", "24387348"]}, {"Citation": "Meijerman I, Beijnen JH, Schellens JH. Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist. 2006;11:742\u2013752. doi: 10.1634/theoncologist.11-7-742.", "ArticleIdList": ["10.1634/theoncologist.11-7-742", "16880233"]}, {"Citation": "Posadzki P, Watson L, Ernst E. Herb-drug interactions: an overview of systematic reviews. Br J Clin Pharmacol. 2013;75:603\u2013618. doi: 10.1111/j.1365-2125.2012.04350.x.", "ArticleIdList": ["10.1111/j.1365-2125.2012.04350.x", "PMC3575928", "22670731"]}, {"Citation": "Caraci F, Crupi R, Drago F, Spina E. Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract. Curr Drug Metab. 2011;12:570\u2013577. doi: 10.2174/138920011795713706.", "ArticleIdList": ["10.2174/138920011795713706", "21395523"]}, {"Citation": "Clarke SJ, McLachlan AJ. Interaction between Complementary and Alternate Medicine with Conventional Anti-cancer Medicine. Cancer Forum. 2011;35:18\u201323."}, {"Citation": "Bonacchi A, et al. Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in Italy. Journal of pain and symptom management. 2014;47:26\u201334. doi: 10.1016/j.jpainsymman.2013.03.014.", "ArticleIdList": ["10.1016/j.jpainsymman.2013.03.014", "23916679"]}, {"Citation": "Huebner J, et al. User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer research. 2014;34:943\u2013948.", "ArticleIdList": ["24511037"]}, {"Citation": "Paul M, et al. Patients with advanced cancer and their usage of complementary and alternative medicine. Journal of cancer research and clinical oncology. 2013;139:1515\u20131522. doi: 10.1007/s00432-013-1460-y.", "ArticleIdList": ["10.1007/s00432-013-1460-y", "23832609"]}, {"Citation": "Horneber M, et al. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integrative cancer therapies. 2012;11:187\u2013203. doi: 10.1177/1534735411423920.", "ArticleIdList": ["10.1177/1534735411423920", "22019489"]}, {"Citation": "Ramos-Esquivel A, Viquez-Jaikel A, Fernandez C. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance. J Oncol Pract. 2017;13:e613\u2013e622. doi: 10.1200/JOP.2017.020859.", "ArticleIdList": ["10.1200/JOP.2017.020859", "28628392"]}, {"Citation": "Patterson RE, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. Journal of alternative and complementary medicine (New York, N.Y.) 2002;8:477\u2013485. doi: 10.1089/107555302760253676.", "ArticleIdList": ["10.1089/107555302760253676", "12230908"]}, {"Citation": "Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society\u2019s studies of cancer survivors. Cancer. 2008;113:1048\u20131057. doi: 10.1002/cncr.23659.", "ArticleIdList": ["10.1002/cncr.23659", "18680170"]}, {"Citation": "Forester SC, Lambert JD. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res. 2011;55:844\u2013854. doi: 10.1002/mnfr.201000641.", "ArticleIdList": ["10.1002/mnfr.201000641", "PMC3679539", "21538850"]}, {"Citation": "Du GJ, et al. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients. 2012;4:1679\u20131691. doi: 10.3390/nu4111679.", "ArticleIdList": ["10.3390/nu4111679", "PMC3509513", "23201840"]}, {"Citation": "Golden EB, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid\u2013based proteasome inhibitors. Blood. 2009;113:5927. doi: 10.1182/blood-2008-07-171389.", "ArticleIdList": ["10.1182/blood-2008-07-171389", "19190249"]}, {"Citation": "Yates JS, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2005;13:806\u2013811. doi: 10.1007/s00520-004-0770-7.", "ArticleIdList": ["10.1007/s00520-004-0770-7", "15711946"]}, {"Citation": "Loquai C, et al. Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients. European journal of cancer. 2017;71:70\u201379. doi: 10.1016/j.ejca.2016.10.029.", "ArticleIdList": ["10.1016/j.ejca.2016.10.029", "27984769"]}, {"Citation": "Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ. 2000;78:252\u2013257.", "ArticleIdList": ["PMC2560678", "10743298"]}, {"Citation": "Frenkel M, Cohen L. Effective communication about the use of complementary and integrative medicine in cancer care. Journal of alternative and complementary medicine (New York, N.Y.) 2014;20:12\u201318. doi: 10.1089/acm.2012.0533.", "ArticleIdList": ["10.1089/acm.2012.0533", "PMC3904534", "23863085"]}, {"Citation": "Hubner J, et al. Counseling cancer patients on complementary and alternative medicine. Background, theory, and implementation of nationwide counseling facilities. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft... [et al] 2013;189:613\u2013617. doi: 10.1007/s00066-013-0392-4.", "ArticleIdList": ["10.1007/s00066-013-0392-4", "23824107"]}, {"Citation": "Berretta M, et al. Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey. Oncotarget. 2017;8:24401\u201324414. doi: 10.18632/oncotarget.14224.", "ArticleIdList": ["10.18632/oncotarget.14224", "PMC5421857", "28212560"]}, {"Citation": "Lee RT, et al. National survey of US oncologists\u2019 knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. J Clin Oncol. 2014;32:4095\u20134101. doi: 10.1200/JCO.2014.55.8676.", "ArticleIdList": ["10.1200/JCO.2014.55.8676", "PMC4517940", "25403205"]}, {"Citation": "Ben-Arye E, et al. Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals. Cancer. 2016;122:598\u2013610. doi: 10.1002/cncr.29796.", "ArticleIdList": ["10.1002/cncr.29796", "26599199"]}, {"Citation": "Chen M, Zhou SY, Fabriaga E, Zhang PH, Zhou Q. Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review. J Food Drug Anal. 2018;26:S61\u2013S71. doi: 10.1016/j.jfda.2018.01.009.", "ArticleIdList": ["10.1016/j.jfda.2018.01.009", "PMC9326888", "29703387"]}, {"Citation": "Mouly S, Lloret-Linares C, Sellier PO, Sene D, Bergmann JF. Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John\u2019s Wort? Pharmacol Res. 2017;118:82\u201392. doi: 10.1016/j.phrs.2016.09.038.", "ArticleIdList": ["10.1016/j.phrs.2016.09.038", "27693910"]}, {"Citation": "Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients. Cancer treatment reviews. 2013;39:773\u2013783. doi: 10.1016/j.ctrv.2012.12.008.", "ArticleIdList": ["10.1016/j.ctrv.2012.12.008", "23394826"]}, {"Citation": "Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta medica. 2012;78:1458\u20131477. doi: 10.1055/s-0032-1315117.", "ArticleIdList": ["10.1055/s-0032-1315117", "22855269"]}, {"Citation": "Shi S, Klotz U. Drug interactions with herbal medicines. Clinical pharmacokinetics. 2012;51:77\u2013104. doi: 10.2165/11597910-000000000-00000.", "ArticleIdList": ["10.2165/11597910-000000000-00000", "22257149"]}, {"Citation": "Aveni E, et al. The Attitudes of Physicians, Nurses, Physical Therapists, and Midwives Toward Complementary Medicine for Chronic Pain: A Survey at an Academic. Hospital. Explore. 2016;12:341\u2013346. doi: 10.1016/j.explore.2016.06.001.", "ArticleIdList": ["10.1016/j.explore.2016.06.001", "27450407"]}, {"Citation": "Foley H, Steel A, Cramer H, Wardle J, Adams J. Disclosure of complementary medicine use to medical providers: a systematic review and meta-analysis. Scientific Reports. 2019;9:1573. doi: 10.1038/s41598-018-38279-8.", "ArticleIdList": ["10.1038/s41598-018-38279-8", "PMC6367405", "30733573"]}, {"Citation": "Katzung, B. G. Pharmacologie fondamentale et clinique. (Piccin, 2006)."}, {"Citation": "Goodman, L. S., Gilman, A., Brunton, L. L., Lazo, J. S. & Parker, K. L. Goodman & Gilman\u2019s the pharmacological basis of therapeutics. (McGraw-Hill, 2006)."}]}], "History": [{"Year": "2018", "Month": "9", "Day": "10"}, {"Year": "2019", "Month": "3", "Day": "12"}, {"Year": "2019", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["30911084", "PMC6434040", "10.1038/s41598-019-41532-3", "10.1038/s41598-019-41532-3"]}}]}